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Salmonellae are a common cause of foodborne dis-
ease worldwide. The World Health Organization (WHO)
supports international foodborne disease surveillance
through WHO Global Salm-Surv and other activities. WHO
Global Salm-Surv members annually report the 15 most
frequently isolated Salmonella serotypes to a Web-based
country databank. We describe the global distribution of
reported Salmonella serotypes from human and nonhuman
sources from 2000 to 2002. Among human isolates,
Salmonella enterica serovar Enteritidis was the most com-
mon serotype, accounting for 65% of all isolates. Among
nonhuman isolates, although no serotype predominated, S.
Typhimurium was reported most frequently. Several
serotypes were reported from only 1 region of the world.
The WHO Global Salm-Surv country databank is a valuable
public health resource; it is a publicly accessible, Web-
based tool that can be used by health professionals to
explore hypotheses related to the sources and distribution
of salmonellae worldwide.
F
oodborne diseases are among the most serious health
problems affecting public health and development
worldwide (1). Industrialization, mass food production,
decreasing trade barriers, and human migration have dis-
seminated and increased the incidence and severity of
foodborne diseases worldwide (2–4).
Salmonellae are among the most common bacterial
foodborne pathogens worldwide (4). They cause an esti-
mated 1.4 million cases of foodborne disease each year in
the United States alone (5).  Salmonella serotyping is a
surveillance tool that detects widespread outbreaks, identi-
fies outbreak sources, monitors trends over time, and
attributes human disease to various foods and animals (6).
Such surveillance is needed to help prevent foodborne dis-
ease outbreaks and raise awareness among health authori-
ties, food producers, food regulators, and consumers (7). 
A 1997 survey of national reference laboratories
showed that only 69 (66%) of 104 responding countries
conducted routine Salmonella serotyping for public health
surveillance (8). Consequently, the World Health
Organization (WHO), the US Centers for Disease Control
and Prevention, and the Danish Veterinary Laboratory
(now the Danish Institute for Food and Veterinary
Research) founded WHO Global Salm-Surv in 2000. Its
mission is to promote integrated, laboratory-based surveil-
lance and foster collaboration among human health, veteri-
nary, and food-related disciplines to enhance the capacity
to detect, respond, and prevent foodborne diseases (9). By
November 2005, WHO Global Salm-Surv had >800 mem-
bers from 142 countries. Akey component of this program
is the Web-based country databank, to which member
countries annually submit their 15 most frequently isolat-
ed Salmonella serotypes. This program is the only food-
borne disease surveillance network that is global in scope
and surveys all aspects of the food chain, from animal feed
to humans. Data are updated annually and are publicly
accessible for members and the scientific community to
review (www.who.int/salmsurv). We describe the global
distribution of Salmonella serotypes from human and non-
human sources reported to the WHO Global Salm-Surv
country databank from 2000 to 2002 and explore how the
databank may become a valuable public health resource
for foodborne disease surveillance.
Methods
WHO Global Salm-Surv has conducted annual region-
al training courses for national reference laboratories since
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assurance program since 2000 to facilitate a standard
approach to isolating and serotyping salmonellae (10).
National reference laboratories can become WHO Global
Salm-Surv members and share Salmonella serotype data
with other members through the country databank. The
country databank is a Web-enabled Oracle database that is
password protected for data entry and accessible for public
viewing at www.who.int/salmsurv. Each year, a designated
national reference laboratory representative enters into the
country databank the number of Salmonella isolates
serotyped from human, animal, food, environmental, and
feed sources and the 15 most frequently identified
serotypes.
Descriptive analysis was conducted by using Microsoft
Excel (Microsoft Corp., Redmond, WA, USA) on data
from all countries that submitted data for 2000, 2001, or
2002 as of June 2004. Analyses for trends over time were
conducted on data from 2000 to 2002. More detailed
analyses, including ranking of serotypes, comparison of
human to nonhuman isolates, and regional comparisons
are presented for 2002 data only, the year in which the
most countries participated.
Before 2001, nonhuman isolates were grouped togeth-
er. Since 2001, countries have been able to submit food,
animal, environmental, and feed data separately. For com-
parison purposes, all nonhuman data were combined in
this analysis.
Data were grouped into regions approximately corre-
sponding to 6 geopolitical continents: Africa, Asia, Latin
America and the Caribbean, Europe, North America, and
Oceania. To accommodate local epidemiologic character-
istics, New Caledonia was incorporated into Asia, and
Israel was incorporated into Europe. For years in which a
single country contributed data for a region, regional data
are not presented, but the data are included in the overall
results. A region-specific serotype was defined as a
serotype that, for each of the years of the study period, was
among the 15 most commonly reported serotypes and for
which >90% of the isolates were from that region. 
Results
Global
Forty-nine countries submitted data to the WHO Global
Salm-Surv country databank from 2000 to 2002 (Table 1).
Twenty countries reported both human and nonhuman
results, 21 reported only human results, and 8 reported
only nonhuman results. Reports of 376,856 human and
65,789 nonhuman Salmonella isolations were entered into
the database during the 3-year period. North America and
Europe accounted for 87.9% (389,134) of all reported iso-
lates. The number of isolates reported to the country data-
bank was stable during the study period; 113,782–137,329
human isolates and 16,506–25,761 nonhuman isolates
were reported per year.
During the 3-year period, Salmonella enterica serovar
Enteritidis was by far the most common serotype reported
from human isolates globally. In 2002, it accounted for
65% of all isolates, followed by S. Typhimurium at 12%
and  S. Newport at 4%. Among nonhuman isolates, S.
Typhimurium was the most commonly reported serotype
in all 3 years, accounting for 17% of isolates in 2002. It
was followed by S. Heidelberg (11%) and S. Enteritidis
(9%) (Figure 1).
In 2002, 26 (84%) of the 31 countries that reported
human serotype results ranked S. Enteritidis and S.
Typhimurium in their 10 most common human serotypes
(Table 2). Approximately half of the countries ranked S.
Infantis and S. Typhi in their 10 most common serotypes,
but only a fourth ranked S. Newport and S. Heidelberg in
their top 10. The relative ranking of serotypes by the num-
ber of countries reporting them in their 15 most frequent
serotypes remained stable over the study period (data not
shown). However, the proportion of countries reporting
each serotype varied. For example, from 2000 to 2001,
more than two thirds of countries reported S. Agona, com-
pared to 39% in 2002. 
In 2002, a total of 5 serotypes were reported among the
15 most common human serotypes from all 6 regions of
the world: S. Enteritidis, S. Typhimurium, S. Infantis, S.
Montevideo, and S. Typhi. However, the proportion of iso-
lates of each serotype varied greatly. In 2002, for example,
S. Enteritidis represented 85% of isolates in Europe but
only 9% in Oceania. In Latin America and the Caribbean,
S. Typhi accounted for the greatest proportion of salmonel-
lae (13%). In 2000 and 2001, S. Enteritidis,  S.
Typhimurium, S. Typhi, and S. Agona were reported from
all 6 regions (data not shown).
S. Enteritidis,  S. Typhimurium, and S. Typhi were
ranked among the 15 most common human serotypes in all
6 regions throughout the 3-year study period. S. Agona, S.
Infantis,  S. Montevideo,  S. Saintpaul,  S. Hadar,  S.
Mbandaka, S. Newport, S. Thompson, S. Heidelberg, and
S. Virchow were also widespread; they were reported from
4 to 6 of the regions from 2000 through 2002. Reporting of
S. Montevideo increased from 4 regions in 2000 to all 6
regions in 2002. The reporting of S. Heidelberg increased
from 3 to 5 regions in the same timeframe.
Regional
In Africa in 2002, S. Enteritidis and S. Typhimurium
were each reported from approximately one fourth of iso-
lates from humans (Figure 2). Among nonhuman sources
(Figure 3), S. Anatum and S. Enteritidis constituted the
largest proportion of isolates.
SYNOPSIS
382 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 3, March 2006Web-based Surveillance and Salmonella Distribution
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 3, March 2006 383In Asia, from 2000 through 2002, Japan, Korea, and
Thailand together reported S. Enteritidis as the most com-
mon human serotype. S. Weltevreden was the second most
common serotype in 2000 and 2001 but dropped to fourth
in 2002, when it was surpassed by S. Rissen and
S. Typhimurium. In 2002, S. Enteritidis accounted for 38%
of human isolates but only 7% of nonhuman isolates.
S. Anatum, S. Rissen, and S. Stanley were the most com-
mon nonhuman serotypes in Asia.
In Europe in 2002, S. Enteritidis accounted for most
salmonellae among human isolates. This trend was con-
stant from 2000 to 2002; S. Enteritidis accounted for 79%
to 84% of isolates, followed by S. Typhimurium in second
place and S. Hadar, S. Virchow, and S. Infantis alternating
in the third to fifth places among the 8 countries that sub-
mitted data during the 3 years. Among nonhuman isolates,
heterogeneity was greater; S. Infantis, S. Enteritidis, and
S. Typhimurium together accounted for 72% of salmonel-
lae in 2002.
In 2002 in Latin America and the Caribbean,
S. Enteritidis was the most common serotype among
human and nonhuman isolates. S. Typhimurium, S. Typhi,
S. Montevideo, and S. Paratyphi B were also commonly
observed among human isolates and S. Typhimurium,
S. Senftenberg,  S. Mbandaka, and S. Agona, among non-
human isolates. During the 3-year period of interest,
S. Enteritidis,  S. Typhimurium, and S. Typhi were the 3
most commonly isolated serotypes among humans in the 5
countries that reported data every year. 
In North America in 2002, S. Typhimurium was more
common than S. Enteritidis among human isolates.
S. Newport and S. Heidelberg also accounted for a sizeable
proportion of the isolates. Among nonhuman isolates, a
corresponding pattern emerges; S. Typhimurium,
S. Heidelberg, and S. Newport were most common.
S. Enteritidis was not reported among the 10 most com-
mon nonhuman serotypes. The relative ranking of
serotypes did not change in the 3-year period; S.
Typhimurium was the most common serotype in humans
and nonhuman isolates from 2000 to 2002. In Oceania in
2000, the only year in which >1 country reported data, S.
Typhimurium accounted for 62% of human Salmonella
isolates, followed by S. Virchow and S. Enteritidis.
Some serotypes were reported among the 15 most com-
mon serotypes in only 1 region during the 3-year period
and therefore were classified as region-specific serotypes.
Africa was the only region to report S. Brancaster among
nonhuman isolates. Asia was the only region to report
S. Rissen (human), S. Panama and S. Stanley (nonhuman),
and S. Weltevreden (human and nonhuman). Europe was
the only region to report S. Blockley,  S. Kisangani,
S. Kottbus, S. Ohio, and S. Stanleyville from human iso-
lates and S. Indiana and S. Isangi from nonhuman isolates.
Latin America and the Caribbean was the only region to
report  S. Bardo,  S. Muenster, and S. Rubislaw among
human isolates. North America was the only region to
report S. Javiana (human) and S. Muenster (nonhuman). 
Discussion
S. Enteritidis is the most common Salmonella serotype
in humans globally but especially in Europe, where it
accounts for 85% of Salmonella cases, Asia (38%), and
Latin America and the Caribbean (31%). The S. Enteritidis
pandemic was first noted in the late 1980s and has been
attributed to contaminated eggs (11). The proportion of
Salmonella infections associated with this serotype seems
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Figure 1. Number of Salmonella isolates
reported by serotype worldwide in 2002.to have increased over time. In 1995, 36% of salmonellae
worldwide were S. Enteritidis, compared to 65% in 2002
(8). 
S. Typhimurium has been 1 of the 2 most frequent
serotypes in humans since 1990 (8). Since S. Enteritidis
and S. Typhimurium are so common, additional subtyping
methods, including phage typing, antimicrobial suscepti-
bility testing, and pulsed-field gel electrophoresis (PFGE),
are needed to identify clusters of infection from the same
source. WHO Global Salm-Surv includes antimicrobial
susceptibility testing training in all regional courses and
has introduced phage typing in the Eastern European
region course. The country databank could include data
from such subtyping efforts. PFGE subtyping data are
exchanged in North American between PulseNet USA and
PulseNet Canada (12). PulseNet International is an affili-
ate member of WHO Global Salm-Surv, and the networks
are coordinating their efforts to ensure synergy.
S. Typhi is a pathogen of concern in the developing
world, especially Asia (13). However, in our analyses, S.
Typhi was the ninth most frequent serotype in Asia in
2002. The Asian countries that contributed to the country
Web-based Surveillance and Salmonella Distribution
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Figure 2. Proportion of most common serotypes of reported human Salmonella isolates by region, 2002.databank did not include many of the developing countries
in south-central and Southeast Asia, where S. Typhi is still
highly prevalent. S. Typhi was the sixth most frequent
serotype globally in 1995 and was decreasing in relative
importance (8). That trend seems to have continued; S.
Typhi ranked 14th globally in 2002. S. Typhi has no animal
reservoir, which makes it susceptible to improvements in
hygiene and sanitation seen in many regions of the world,
such as Latin America and the Caribbean.
The distribution of nonhuman serotypes is more hetero-
geneous than that of human serotypes. The same serotypes
appear among the top 5 in human and nonhuman sources,
although in a different order. S. Enteritidis is only the third
most common serotype among nonhuman sources. In
2002, it was not reported at all among the 10 most common
nonhuman serotypes from North America. This finding
partly reflects the capacity of S. Enteritidis to contaminate
eggs in low numbers and the difficulty of isolating it from
food or the environment. Moreover, in North America, few
samples from eggs are submitted for routine testing. For
example, in the United States, routine testing of eggs is not
required, whereas routine testing for salmonellae is
required of meat and poultry plants. As eggs are frequent-
ly used in foods that do not undergo heat treatment (e.g.,
pastries, homemade ice cream, and mayonnaise) and are
widely distributed, this food contamination has a substan-
tial effect on public health.
The country databank contains far fewer nonhuman
than human serotypes, possibly because more participating
laboratories are human national reference laboratories,
fewer countries have formal nonhuman surveillance, and
some countries may be less likely to share nonhuman data
because of trade concerns. In 2001 and 2002, 15 of 22
countries reported nonhuman isolates by source. Food
serotypes were reported from most countries (11 in 2001
and 12 in 2002), followed by animal serotypes (7 countries
in 2001 and 10 in 2002). Most isolates serotyped were
from animals (66%), followed by food (29%), feed (3%),
and the environment (2%). The reporting of S.
Weltevreden from the environment, feed, animals, food,
and humans in Southeast Asia is an example of how the
country databank can be used to track Salmonella
serotypes along the food chain.
Many serotypes are restricted to a single region of the
world. This finding may reflect an ecologic niche or a local
food source that is not exported. A number of such exam-
ples have been reported in the past, such as S. Marina asso-
ciated with marine iguanas from South America found in
the United States and S. Tilene in imported African pygmy
hedgehogs in the United States and Canada (14–16). The
country databank is uniquely placed to allow countries to
observe this phenomenon. Investigators have reported
infections of S. Javiana associated with exposure to wild
amphibians in a confined area in the southeastern United
States (17). According to the country databank, S. Javiana
is only reported among the 15 most common serotypes in
the United States. In 2001, the WHO Global Salm-Surv
country databank helped confirm that S. Weltevreden was
largely restricted to Southeast Asia. A survey of Southeast
Asian laboratories showed that items most frequently asso-
ciated with this serotype include seafood, water, and Asian
vegetables (18). In the same region, S. Rissen has
increased in both human and nonhuman sources (19). The
country databank allows countries to become aware that a
common serotype in their country may be rare elsewhere
in the world, leading to hypothesis generation in outbreaks
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Figure 3. Proportion of most common serotypes of reported nonhuman Salmonella isolates by region, 2002.and studies to understand the sources of disease. Countries
that report a large number of isolates to the country data-
bank, such as North American and European countries,
typically do not report rare serotypes because these would
not rank in their top 15, thus limiting the ability to track
rare serotypes in these countries.
Countries with fewer resources may lack complete anti-
sera kits necessary to identify certain serotypes, which
would lead to underreporting. For example, although we
assume that S. Enteritidis human infections occur globally,
a number of countries in Asia, Africa, and Latin America
and the Caribbean did not report this serotype in their top
10 (Table 2). Lack of resources can also cause misclassifi-
cation of serotypes. For example, S. Paratyphi B was
reported to be among the most common serotypes in Latin
America and the Caribbean. However, some countries in
the region lack the capacity to differentiate between S.
Paratyphi B and S. Paratyphi B tartrate var. Java.
In general, industrialized countries are more likely to
regularly contribute to the country databank and to report
more isolates. The results are therefore biased towards the
industrialized world. However, the country databank lacks
data from many Western European countries. Twenty-four
European countries report human Salmonella serotype
results annually to Enter-net, a European-based surveil-
lance network for gastrointestinal infections, as compared
to only 14 reporting to WHO Global Salm-Surv from 2000
to 2002. A review of recent Enter-net data confirms that S.
Enteritidis is by far the most commonly isolated serotype
in Europe but at a lower proportion than that reported to
WHO Global Salm-Surv; 68%–71% of Enter-net
Salmonella isolates were S. Enteritidis from 2000 to 2002
(Ian Fisher, pers. comm.) (20). A recent agreement
between WHO Global Salm-Surv and Enter-net will lead
to routine electronic sharing of data between the 2 systems
to improve efficiency and representativeness (Henrik
Wegener, pers. comm.).
Serotypes reported by a region are not necessarily cir-
culating locally and may have been imported through trav-
el or traded foods. Intraregional comparisons are limited
by the fact that case definitions and surveillance systems
vary between countries. The country databank does not
collect the source of isolation. Some countries may report
salmonellae isolated from both blood and stool and others
from stool only. The low number of isolates and countries
reporting nonhuman data and the pooling of food, animal,
environmental, and feed sources hamper further analysis
of nonhuman data. Some regional results may not be rep-
resentative, since some regions have few countries report-
ing data to the country databank (e.g., Africa). 
Some countries may not submit data to the country
databank because of concern regarding international trad-
ing of food. Others do not have the supplies or training
necessary to conduct serotyping. WHO Global Salm-Surv
training courses were launched in Southeast Asia in 1999
and expanded to South America and the Middle East in
2000; China, Central America, and the Caribbean in 2001;
and West Africa and Eastern Europe in 2002 (www.who.
int/salmsurv). All participating countries were initially
provided with antisera to conduct serotyping. WHO
Global Salm-Surv established an external quality assur-
ance system (EQAS) in 2000 to assess the accuracy of
serotyping and antimicrobial susceptibility testing among
member national reference laboratories. From 2000 to
2002, the number of laboratories participating in EQAS
increased from 44 to 117, and the capacity to correctly
serotype 8 Salmonella isolates improved from 76% to 90%
of participating laboratories (21). The increased reporting
of certain serotypes during the study period may be due to
capacity improvement and increased participation in the
country databank as well as real changes in the epidemio-
logic features of salmonellae. For example, S. Montevideo
was first reported in Africa in 2001. In 2002, Tunisia par-
ticipated in the country databank for the first time and
reported S. Montevideo in its top 15 (increased participa-
tion). Oceania started reporting S. Montevideo in its top 15
in 2002 for the first time since participating in the country
databank (change in epidemiologic features).
Data are not entered into the country databank in a
timely enough way to detect international outbreaks.
However, regularly monitoring the data can allow emerg-
ing trends in regional and international Salmonella epi-
demiology and region-specific serotypes to be detected.
This information in turn leads to hypothesis generation,
studies, and international collaboration to improve control
of salmonellae in the long term. Examples of such work
include the surveillance of Salmonella serotypes and
antimicrobial drug resistance in South America, China,
and the Democratic Republic of Congo; the assessment of
risk factors for and drug resistance of S. Weltevreden in
Southeast Asia; and the molecular characterization of S.
Corvallis isolates from Bulgaria, Thailand, and Denmark
(18,22–26, F. Aarestrup, pers. comm.).
The WHO Global Salm-Surv Country Databank is a
valuable resource for international Salmonella surveillance.
Past attempts to characterize Salmonella serotype distribu-
tion globally have either not been widely accessible or
relied on irregular surveys of laboratories (8,11). Trends in
global Salmonella epidemiology can now be updated and
followed across regions and over time. In an era when most
national institutions have access to the Internet, using a
Web-based data collection tool is both feasible and practi-
cal. The data are immediately and publicly accessible for
viewing and analysis (www.who.int/salmsurv). The results
have several limitations in terms of representativeness and
comparability but can be used to follow trends, generate
Web-based Surveillance and Salmonella Distribution
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This surveillance is a step toward improving the under-
standing and control of salmonellae worldwide.
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